SCHEMBL16265270

SCHEMBL16265270

CCCCCc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccc(OCCCC)cc5F)s4)c4nsnc34)s2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 4/20 0.39
▸ S1PR3 Q99500 2/20 0.39
▸ MEN1 O00255 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SLCO1B3 Q9NPD5 1/20 0.36
▸ SLCO1B1 Q9Y6L6 1/20 0.36
▸ RARB P10826 1/20 0.35
▸ PDK2 Q15119 3/20 0.34
▸ PLA2G4A P47712 2/20 0.34
▸ C3AR1 Q16581 1/20 0.33
▸ PTPN11 Q06124 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17694315 0.91 RARB (0.40) S1PR1RARBRAB9A
SCHEMBL17694324 0.90 RARB (0.39) S1PR1RARBRAB9A
SCHEMBL17694316 0.90 RARB (0.42) ALDH1A1LMNACYP3A4RARBRAB9A
SCHEMBL17694346 0.90 RARB (0.39) S1PR1RARBRAB9A
SCHEMBL17694321 0.89 RARB (0.39) S1PR1RARBPDK2RAB9A
SCHEMBL22268268 0.87 S1PR1 (0.42) S1PR1S1PR3MEN1USP2ALDH1A1
SCHEMBL16265326 0.87 AHR (0.38) S1PR1S1PR3MEN1ALDH1A1MAPK1
SCHEMBL17694363 0.86 HRH3 (0.35) S1PR1S1PR3MEN1ALDH1A1KMT2A
SCHEMBL18418552 0.85 PDK2 (0.36) S1PR1S1PR3MEN1USP2ALDH1A1
SCHEMBL17694323 0.84 RARB (0.40) S1PR1RARBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017118464-A1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2017-07-13 — — WO disclosed
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 — — US disclosed
US-20160319592-A1 DEVICE FOR REGULATING THE PASSAGE OF LIGHT MERCK PATENT GMBH (DE) 2016-11-03 — — US disclosed
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2016-04-21 — — US disclosed
WO-2014187529-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2014-11-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND CRY1, SLC25A1, CRY2 S1PR1 4364/4885S1PR3 4636/4885MEN1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback